Literature DB >> 22536816

Clostridium difficile infection in the community: a zoonotic disease?

M P M Hensgens1, E C Keessen, M M Squire, T V Riley, M G J Koene, E de Boer, L J A Lipman, E J Kuijper.   

Abstract

Clostridium difficile infections (CDIs) are traditionally seen in elderly and hospitalized patients who have used antibiotic therapy. In the community, CDIs requiring a visit to a general practitioner are increasingly occurring among young and relatively healthy individuals without known predisposing factors. C. difficile is also found as a commensal or pathogen in the intestinal tracts of most mammals, and various birds and reptiles. In the environment, including soil and water, C. difficile may be ubiquitous; however, this is based on limited evidence. Food products such as (processed) meat, fish and vegetables can also contain C. difficile, but studies conducted in Europe report lower prevalence rates than in North America. Absolute counts of toxigenic C. difficile in the environment and food are low, however the exact infectious dose is unknown. To date, direct transmission of C. difficile from animals, food or the environment to humans has not been proven, although similar PCR ribotypes are found. We therefore believe that the overall epidemiology of human CDI is not driven by amplification in animals or other sources. As no outbreaks of CDI have been reported among humans in the community, host factors that increase vulnerability to CDI might be of more importance than increased exposure to C. difficile. Conversely, emerging C. difficile ribotype 078 is found in high numbers in piglets, calves, and their immediate environment. Although there is no direct evidence proving transmission to humans, circumstantial evidence points towards a zoonotic potential of this type. In future emerging PCR ribotypes, zoonotic potential needs to be considered.
© 2012 The Authors. Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22536816     DOI: 10.1111/j.1469-0691.2012.03853.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  82 in total

Review 1.  Dentists, antibiotics and Clostridium difficile-associated disease.

Authors:  N Beacher; M P Sweeney; J Bagg
Journal:  Br Dent J       Date:  2015-09-25       Impact factor: 1.626

2.  Immunochromatographic test and ELISA for the detection of glutamate dehydrogenase (GDH) and A/B toxins as an alternative for the diagnosis of Clostridioides (Clostridium) difficile-associated diarrhea in foals and neonatal piglets.

Authors:  Carolina Pantuzza Ramos; Emily Oliveira Lopes; Carlos Augusto Oliveira Júnior; Amanda Nádia Diniz; Francisco Carlos Faria Lobato; Rodrigo Otávio Silveira Silva
Journal:  Braz J Microbiol       Date:  2020-05-03       Impact factor: 2.476

Review 3.  Vaccines against Clostridium difficile.

Authors:  Rosanna Leuzzi; Roberto Adamo; Maria Scarselli
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

4.  Prevalence of Clostridium difficile isolated from various raw meats in Korea.

Authors:  Joo Young Lee; Da Yeon Lee; Yong Sun Cho
Journal:  Food Sci Biotechnol       Date:  2018-01-24       Impact factor: 2.391

5.  Environmental Factors Associated with the Carriage of Bacterial Pathogens in Norway Rats.

Authors:  Jamie L Rothenburger; Chelsea G Himsworth; Nicole M Nemeth; David L Pearl; Claire M Jardine
Journal:  Ecohealth       Date:  2018-02-09       Impact factor: 3.184

Review 6.  Clostridioides difficile Spores: Bile Acid Sensors and Trojan Horses of Transmission.

Authors:  Aimee Shen
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

Review 7.  Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance.

Authors:  Kathleen Mullane
Journal:  Ther Adv Chronic Dis       Date:  2014-03       Impact factor: 5.091

Review 8.  The livestock reservoir for antimicrobial resistance: a personal view on changing patterns of risks, effects of interventions and the way forward.

Authors:  Frank M Aarestrup
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-05       Impact factor: 6.237

Review 9.  Clostridium difficile infection: epidemiology, diagnosis and understanding transmission.

Authors:  Jessica S H Martin; Tanya M Monaghan; Mark H Wilcox
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-03-09       Impact factor: 46.802

10.  Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain.

Authors:  Dolors Rodríguez-Pardo; Benito Almirante; Rosa M Bartolomé; Virginia Pomar; Beatriz Mirelis; Ferran Navarro; Alex Soriano; Luisa Sorlí; Joaquín Martínez-Montauti; Maria Teresa Molins; Maily Lung; Jordi Vila; Albert Pahissa
Journal:  J Clin Microbiol       Date:  2013-02-27       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.